Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation

[1]  M. Bradley,et al.  A Synthetic Polymer Scaffold Reveals the Self‐Maintenance Strategies of Rat Glioma Stem Cells by Organization of the Advantageous Niche , 2016, Stem cells.

[2]  M. Jinushi,et al.  Induction of protumoral CD11chigh macrophages by glioma cancer stem cells through GM‐CSF , 2016, Genes to cells : devoted to molecular & cellular mechanisms.

[3]  Nupur K. Das,et al.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells. , 2015, Cancer cell.

[4]  Bin Chen,et al.  ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy , 2015, Scientific Reports.

[5]  Y. Hagiya,et al.  The Effect of Iron Ion on the Specificity of Photodynamic Therapy with 5-Aminolevulinic Acid , 2015, PloS one.

[6]  Y. Hagiya,et al.  Effects of plasma membrane ABCB6 on 5-aminolevulinic acid (ALA)-induced porphyrin accumulation in vitro: tumor cell response to hypoxia. , 2015, Photodiagnosis and photodynamic therapy.

[7]  B. Pogue,et al.  Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis , 2014, Journal of biomedical optics.

[8]  Yaohua Liu,et al.  Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma , 2014, Acta oncologica.

[9]  R. Scienza,et al.  Phenotypic and functional characterization of Glioblastoma cancer stem cells identified trough 5-aminolevulinic acid-assisted surgery , 2014, Journal of Neuro-Oncology.

[10]  Herbert Stepp,et al.  5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging , 2013, Neurosurgery.

[11]  Hsuan‐Shu Lee,et al.  Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2‐deficient hepatocytes , 2013, FEBS letters.

[12]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[13]  N. Rainov,et al.  Increased Expression of ABCB6 Enhances Protoporphyrin IX Accumulation and Photodynamic Effect in Human Glioma , 2013, Annals of Surgical Oncology.

[14]  Gabrielle Brown,et al.  Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications. , 2013, The Journal of surgical research.

[15]  Edward Kai-Hua Chow,et al.  Mechanisms of chemoresistance in cancer stem cells , 2013, Clinical and Translational Medicine.

[16]  T. Ishikawa,et al.  Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro. , 2012, Photodiagnosis and photodynamic therapy.

[17]  E. Cassinerio,et al.  An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.

[18]  J. Griffiths,et al.  Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin , 2012, British Journal of Cancer.

[19]  T. Hasan,et al.  Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. , 2011, Cancer research.

[20]  T. Ishikawa,et al.  Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors , 2011, Pharmaceutics.

[21]  J. Rich,et al.  Deadly teamwork: neural cancer stem cells and the tumor microenvironment. , 2011, Cell stem cell.

[22]  Michael R Hamblin,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[23]  Katsushi Inoue,et al.  Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. , 2011, International immunopharmacology.

[24]  J. Hamada,et al.  Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy , 2011, British Journal of Cancer.

[25]  S. Niclou,et al.  Critical appraisal of the side population assay in stem cell and cancer stem cell research. , 2011, Cell stem cell.

[26]  H. Tsuda,et al.  Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma. , 2010, International journal of oral and maxillofacial surgery.

[27]  T. Ishikawa,et al.  Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis , 2010, Advances in pharmacological sciences.

[28]  Brian W Pogue,et al.  Review of Neurosurgical Fluorescence Imaging Methodologies , 2010, IEEE Journal of Selected Topics in Quantum Electronics.

[29]  B. Pogue,et al.  Deferoxamine Iron Chelation Increases δ‐Aminolevulinic Acid Induced Protoporphyrin IX in Xenograft Glioma Model , 2010, Photochemistry and photobiology.

[30]  Shan Jiang,et al.  Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines , 2010, Lasers in Medical Science.

[31]  J. Kwiatkowski.  Oral iron chelators. , 2010, Hematology/oncology clinics of North America.

[32]  W. Gallagher,et al.  Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.

[33]  M. Miyake,et al.  siRNA‐mediated Knockdown of the Heme Synthesis and Degradation Pathways: Modulation of Treatment Effect of 5‐Aminolevulinic Acid‐based Photodynamic Therapy in Urothelial Cancer Cell Lines , 2009, Photochemistry and photobiology.

[34]  R. Tampé,et al.  Mitochondrial ABC proteins in health and disease. , 2009, Biochimica et biophysica acta.

[35]  Ulf Norinder,et al.  Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.

[36]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[37]  N. Partovi,et al.  Iron Overload Disorders: Treatment Options for Patients Refractory to or Intolerant of Phlebotomy , 2008, Pharmacotherapy.

[38]  H. Biesalski,et al.  Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. , 2007, International journal of oncology.

[39]  A. Oseroff,et al.  The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2 , 2007, Clinical Cancer Research.

[40]  T. Hasan,et al.  Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells , 2006, British Journal of Cancer.

[41]  Georges Wagnières,et al.  On the Role of Iron and one of its Chelating Agents in the Production of Protoporphyrin IX Generated by 5-Aminolevulinic Acid and its Hexyl Ester Derivative Tested on an Epidermal Equivalent of Human Skin , 2006, Photochemistry and photobiology.

[42]  D. Nowis,et al.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity , 2006, Oncogene.

[43]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[44]  J. Moan,et al.  Deferoxamine photosensitizes cancer cells in vitro. , 2005, Biochemical and biophysical research communications.

[45]  S. Bates,et al.  ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy , 2005, Cancer biology & therapy.

[46]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[47]  T. Kondo,et al.  Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Brian C Wilson,et al.  Molecular Fluorescence Excitation–Emission Matrices Relevant to Tissue Spectroscopy¶ , 2003, Photochemistry and photobiology.

[49]  F. Bach,et al.  Heme oxygenase-1: unleashing the protective properties of heme. , 2003, Trends in immunology.

[50]  L E Rhodes,et al.  The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5‐aminolaevulinic acid photodynamic therapy , 2003, The British journal of dermatology.

[51]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[52]  P. A. Peterson,et al.  The roles of iron in health and disease. , 2001, Molecular aspects of medicine.

[53]  D. Richardson,et al.  The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. , 1994, Cancer research.

[54]  W. Sweet,et al.  Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. , 1971, Journal of neurosurgery.

[55]  E. Kelly,et al.  an update on , 2014 .

[56]  T. Ishikawa,et al.  Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors. , 2011, Pharmaceutics.

[57]  Ja Eun Kim.  Mechanism for enhanced 5- aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas , 2008 .